Aging of the united states population: Impact on heart failure

Current Heart Failure Reports

Volumn 9, Issue 4, 2012, Pages 369-374

  Vigen, Rebecca ^a,b,c   Maddox, Thomas M ^a,b,c   Allen, Larry A ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Medicine   (United States)

Author keywords

Aging; Epidemiology .Treatment; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ACUTE HEART INFARCTION; AGING; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DRUG WITHDRAWAL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; PRESCRIPTION; VALVULAR HEART DISEASE; WHEEZING;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; HEALTH RESOURCES; HEART FAILURE; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; UNITED STATES;

EID: 84872172492     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-012-0114-8     Document Type: Article

References (40)

1. United States Census Bureau. Projections of the Population by Selected Age Groups and Sex for the United States: 2010 to 2050. 2008. Available at www.census.gov/population/www/projections/summarytables.html. Accessed July 2012.
2. Werner CA. The Older Population: 2010. The 2010 Census Briefs, November 2011.
3. National Institute on Aging NIH, U.S. Department of Health and Human Services, U.S. Department of State. Why Population Aging Matters: A Global Perspective. 2007:1-32.
4. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933-44.
5. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
6. National Institutes of Health: NHLBI. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases.
7. National Institutes of Health: NHLBI. Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases.
8. Butler J, Kalogeropoulos AP, Georgiopoulou VV, et al. Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart. 2011;97(16):1304-11.
9. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068-72.
10. Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med. 2009;169(7):708-15.
11. Yoon S, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief. 2010;48:1-8.
12. Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction. Circulation. 2008;118(20):2057-62.
13. Mann D, Reynolds K, Smith D, Muntner P. Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines. Ann Pharmacother. 2008;42(9):1208-15.
14. Committee on Reducing Tobacco Use: Strategies B, Consequences. Ending the Tobacco Problem: A Blueprint for the Nation: The National Academies Press; 2007.
15. Yeh RW, Sidney S, Chandra M, et al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med. 2010;362(23):2155-65.
16. Kannel WB. Incidence and epidemiology of heart failure. Hear Fail Rev. 2000;5(2):167-73.
17. Murad K, Kitzman D. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Hear Fail Rev. 2012;17(4):581-8.
18. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥65 years of age. Am J Cardiol. 2001;87(4):413-9. (Pubitemid 32149998)
19. Owan TE, Hodge DO, Herges RM, et al. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2006;355(3):251-9. (Pubitemid 44079340)
20. Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in Patients Hospitalized with Heart Failure and Preserved Left Ventricular Ejection Fraction -Prevalence, Therapies, and Outcomes. Circulation. 2012. This study describes differences in demographics, comorbidities, prevalence, and outcomes among patients with heart failure and normal ejection fraction versus those with borderline and reduced ejection fraction who are hospitalized for heart failure.
21. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550-6.
22. Krum H, Hill J, Fruhwald F, et al. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study. Eur J Hear Fail. 2006;8(3):302-7.
23. Muzzarelli S, Maeder MT, Toggweiler S, et al. Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy. Am J Cardiol. 2012;109(5):693-8.
24. Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Hear J. 2009;30(4):478-86. This study compares the management and outcomes among octogenarians and younger adults hospitalized with heart failure across Europe. Management and outcomes are also compared across time, between 2000-2001 and 2004-2005.
25. Santangeli P, Di Biase L, Dello Russo A, et al. Meta-Analysis: age and effectiveness of prophylactic implantable cardioverterdefibrillators. Ann Intern Med. 2010;153(9):592-9.
26. Alsheikh-Ali AA, Trikalinos TA, Ruthazer R, et al. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J. 2011;161(1):204-9.e1. This study shows that the proportion of patients who die from nonarrhythmic versus arrhythmic death increases among patients with advanced heart failure and chronic kidney disease.
27. Ahluwalia SC, Gross CP, Chaudhry SI, et al. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Int Med. 2011;26(10):1145-51. This retrospective cohort study of Medicare beneficiaries with heart failure describes the increasing incidence of comorbidities with age.
28. van Kan GA, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26(2):275-86.
29. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56 (3):M146-56.
30. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M158-66.
31. Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-Term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2005;35(12):723-30.
32. Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928-52.
33. Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes. 2011;4(1):68-75.
34. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226-33.
35. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777-81.
36. Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215-25.
37. Cleland JGF, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338-45.
38. Bhuiyan T, Maurer M. Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma. Curr Cardiovasc Risk Rep. 2011;5(5):440-9.
39. Goebel JR, Doering LV, Shugarman LR, Asch SM, Sherbourne CD, Lanto AB, et al. Heart failure: the hidden problem of pain. J Pain Symptom Manag. 2009;38(5):698-707.
40. Bekelman DB, Havranek EP. Palliative care for patients with acute decompensated heart failure: an underused service? Nat Clin Pract Cardiovasc Med. 2008;5(5):250-1. (Pubitemid 351593905)